Tuncer Altug, Adademir Taylan, Tuncer Eylem, Tas Serpil Gezer, Donmez Arzu Antal, Sunar Hasan, Balkanay Mehmet
Department of Cardiovascular Surgery, Kartal Koşuyolu Heart and Research Hospital, Istanbul, Turkey.
Heart Surg Forum. 2012 Feb;15(1):E23-7. doi: 10.1532/HSF98.20111094.
Total axilloaxillary cardiopulmonary bypass (CPB) is an alternative peripheral cannulation technique that has the advantages of antegrade flow during CPB, monohemispherical brain perfusion in case of circulatory arrest, and achieving excellent decompression of the heart during sternotomy. The results of this strategy, particularly beyond the immediately postoperative period, are not well known.
Eleven patients with huge aortic aneurysms (>80 mm) and/or acute-subacute ascending aorta dissections underwent surgery with totally axilloaxillary CPB. Short- and midterm outcomes, including survival and complications relating to axilloaxillary cannulation, were reported.
All attempts at axillary artery cannulation were successful. Ten of the 11 axillary vein cannulation attempts were successful, and the target pump flow was achieved via the axillary vein alone. Postoperatively, clinical examinations revealed no cases of arm ischemia or compartment syndrome. Three patients (27.3%) experienced ipsilateral brachial plexus neuropathy that produced right hand weakness. The neuropathy was transient in 2 patients, and the symptoms resolved completely. Hospital death occurred in 1 (9.1%) of the 11 patients. The mean (±SD) follow-up time was 956 ± 292 days. One of the survivors died on postoperative day 105 from subacute graft infection and sepsis. The right arms of all 9 of the living patients were examined physically and by Doppler ultrasonography. We found a chronic recanalized thrombotic change in the subclavian vein in 1 patient (11.1%), who had no complaints.
Axilloaxillary CPB is an alternative technique that can be used under certain conditions. Adding axillary venous cannulation to axillary artery cannulation at least does not increase the risk of a procedure that uses the axillary artery alone, either in the early or mid term.
全腋动脉-腋静脉体外循环(CPB)是一种替代性的外周插管技术,具有在CPB期间顺行血流、循环骤停时单半球脑灌注以及在开胸手术期间实现心脏良好减压的优点。该策略的结果,尤其是术后近期以外的结果,尚不清楚。
11例巨大主动脉瘤(>80mm)和/或急性-亚急性升主动脉夹层患者接受了全腋动脉-腋静脉CPB手术。报告了短期和中期结果,包括生存情况以及与腋动脉-腋静脉插管相关的并发症。
所有腋动脉插管尝试均成功。11例腋静脉插管尝试中有10例成功,仅通过腋静脉就实现了目标泵流量。术后,临床检查未发现手臂缺血或骨筋膜室综合征病例。3例患者(27.3%)出现同侧臂丛神经病变,导致右手无力。2例患者的神经病变为短暂性,症状完全缓解。11例患者中有1例(9.1%)发生医院死亡。平均(±标准差)随访时间为956±292天。1例幸存者在术后第105天死于亚急性移植物感染和脓毒症。对所有9例存活患者的右臂进行了体格检查和多普勒超声检查。我们发现1例患者(11.1%)的锁骨下静脉有慢性再通血栓形成改变,该患者无任何不适主诉。
腋动脉-腋静脉CPB是一种在特定条件下可采用的替代技术。至少在早期或中期,在腋动脉插管基础上增加腋静脉插管不会增加仅使用腋动脉的手术风险。